| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
4e-15 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-14 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
8e-13 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-12 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-10 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-09 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-09 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-09 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-08 |
| mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-08 |